Position in BIVI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$137,257
+$19,373 QoQ
Shares Held
70,752
-16.0% QoQ
Ownership
0.938%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 36 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,872,883,090 across 520 Biotechnology names. BIVI ranks #425 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BIVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,257 | 70,752 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $117,884 | 84,203 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $64,241 | 55,381 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $99,510 | 52,374 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $128,945 | 139,401 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $135,261 | 138,023 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $246,816 | 123,408 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $45,808 | 38,174 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $92,893 | 231,656 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $130,719 | 247,106 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $236,362 | 187,589 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $471,991 | 138,414 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $652,857 | 151,475 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $971,224 | 120,201 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $595,104 | 76,590 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $98,200 | 39,438 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $57,185 | 39,438 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $162,306 | 34,387 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $127,656 | 28,368 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $126,795 | 18,953 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $388,121 | 22,898 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $410,008 | 21,200 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||